Evofem Biosciences Share Holder Equity 2013-2022 | EVFM
Evofem Biosciences share holder equity from 2013 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
Evofem Biosciences Annual Share Holder Equity (Millions of US $) |
2021 |
$-100 |
2020 |
$1 |
2019 |
$16 |
2018 |
$-23 |
2017 |
$-100 |
2016 |
$12 |
2015 |
$24 |
2014 |
$65 |
2013 |
$3 |
2012 |
$11 |
Evofem Biosciences Quarterly Share Holder Equity (Millions of US $) |
2022-03-31 |
$-124 |
2021-12-31 |
$-100 |
2021-09-30 |
$-59 |
2021-06-30 |
$9 |
2021-03-31 |
$-14 |
2020-12-31 |
$1 |
2020-09-30 |
$40 |
2020-06-30 |
$69 |
2020-03-31 |
$1 |
2019-12-31 |
$16 |
2019-09-30 |
$24 |
2019-06-30 |
$36 |
2019-03-31 |
$-29 |
2018-12-31 |
$-23 |
2018-09-30 |
$-10 |
2018-06-30 |
$5 |
2018-03-31 |
$-18 |
2017-12-31 |
$-100 |
2017-09-30 |
$5 |
2017-06-30 |
$7 |
2017-03-31 |
$9 |
2016-12-31 |
$12 |
2016-09-30 |
$14 |
2016-06-30 |
$16 |
2016-03-31 |
$19 |
2015-12-31 |
$24 |
2015-09-30 |
$33 |
2015-06-30 |
$50 |
2015-03-31 |
$59 |
2014-12-31 |
$65 |
2014-09-30 |
$0 |
2014-06-30 |
$0 |
2014-03-31 |
$0 |
2013-12-31 |
$3 |
2012-12-31 |
$11 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$0.005B |
$0.008B |
Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention of acquisition of sexually transmitted infections and products which address or promote general health and wellbeing. Evofem Biosciences Inc., formerly known as Neothetics Inc., is based in SAN DIEGO CA.
|